Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""Hydroxychloroquine"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 10231 results

Research starter:

Title:
Quality-by-design ecofriendly potentiometric sensor for rapid monitoring of hydroxychloroquine purity in the presence of toxic impurities.
Authors:
Draz ME; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
Edrees FH; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Nahda University (NUB), Beni-Suef, 62511, Egypt. .
Mohamed HM; Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo, 11562, Egypt.
Hammad SF; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Egypt.; Medicinal Chemistry Department, PharmD Program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, Alexandria, 21934, Egypt.
Saad AS; Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo, 11562, Egypt.; Medicinal Chemistry Department, PharmD Program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, Alexandria, 21934, Egypt.
Show more
Source:
Scientific reports [Sci Rep] 2024 Mar 22; Vol. 14 (1), pp. 6869. Date of Electronic Publication: 2024 Mar 22.
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/analysis
Hydroxychloroquine*/standards
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
2-Deoxyglucose and hydroxychloroquine HPLC-MS-MS analytical methods and pharmacokinetic interactions after oral co-administration in male rats.
Authors:
Sun D; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.; Pennsylvania State University College of Medicine Mass Spectrometry Core Facility, Hershey, Pennsylvania, USA.
Kim S; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Karelia D; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Deng Y; Department of Urology, University of Minnesota College of Medicine, Minneapolis, Minnesota, USA.
Jiang C; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Lü J; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA.
Show more
Source:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1173.
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/pharmacokinetics
Liquid Chromatography-Mass Spectrometry*
Male ; Rats ; Animals ; Chromatography, High Pressure Liquid ; Administration, Oral ; Deoxyglucose
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A temporary regulation to manage an impending shortage due to extraordinary prescribing patterns of chloroquines observed during early phase of COVID-19 epidemic.
Authors:
Kälkner KM; Swedish Medical Products Agency, Uppsala, Sweden.
Sundström A; Swedish Medical Products Agency, Uppsala, Sweden.
Haverinen MJ; Region Stockholm, Stockholm, Sweden.
Nordback K; Swedish Medical Products Agency, Uppsala, Sweden.
Arthurson V; Swedish Medical Products Agency, Uppsala, Sweden.
Zethelius B; Swedish Medical Products Agency, Uppsala, Sweden.
Ljung R; Swedish Medical Products Agency, Uppsala, Sweden.
Show more
Source:
Upsala journal of medical sciences [Ups J Med Sci] 2023 Dec 31; Vol. 128. Date of Electronic Publication: 2023 Dec 31 (Print Publication: 2023).
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/therapeutic use
COVID-19*
Humans ; SARS-CoV-2 ; COVID-19 Drug Treatment ; Chloroquine
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Optical coherence tomography angiography parameters in patients taking hydroxychloroquine therapy.
Authors:
Vasilijević JB; Clinic for Eye Diseases, University Clinical Centre of Serbia, Belgrade; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Kovačević IM; Clinic for Eye Diseases, University Clinical Centre of Serbia, Belgrade; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Dijana R; Clinic for Eye Diseases, University Clinical Centre of Serbia, Belgrade; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Dačić B; Clinic for Eye Diseases, University Clinical Centre of Serbia, Belgrade; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Marić G; Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Serbia.
Stanojlović S; Clinic for Eye Diseases, University Clinical Centre of Serbia, Belgrade; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Show more
Source:
Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Oct; Vol. 71 (10), pp. 3399-3405.
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/adverse effects
Autoimmune Diseases*
Humans ; Fluorescein Angiography/methods ; Tomography, Optical Coherence/methods ; Cross-Sectional Studies ; Retinal Vessels/diagnostic imaging
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Hydroxychloroquine reduces T cells activation recall antigen responses.
Authors:
Kowatsch MM; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Lajoie J; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Mwangi L; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Omollo K; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Oyugi J; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.; Partners for Health and Development in Africa, Nairobi, Kenya.; University of Nairobi Institute for Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Hollett N; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Kimani J; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.; Partners for Health and Development in Africa, Nairobi, Kenya.; University of Nairobi Institute for Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Fowke KR; Laboratory of Viral Immunology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.; Partners for Health and Development in Africa, Nairobi, Kenya.; Department of Community Health Science, University of Manitoba, Winnipeg, Manitoba, Canada.
Show more
Source:
PloS one [PLoS One] 2023 Aug 02; Vol. 18 (8), pp. e0287738. Date of Electronic Publication: 2023 Aug 02 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/pharmacology
Hydroxychloroquine*/therapeutic use
COVID-19*
Humans ; Leukocytes, Mononuclear ; Tumor Necrosis Factor Receptor Superfamily, Member 7 ; COVID-19 Vaccines ; Pandemics ; COVID-19 Drug Treatment ; Cytokines
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Commentary on 'Optical coherence tomography angiography parameters in patients taking hydroxychloroquine therapy - cross-sectional study'.
Authors:
Chakraborty D; Disha Eye Hospitals, 88 Ghosh Para Road Barrackpore, Kolkata, West Bengal, India.
Show more
Source:
Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Oct; Vol. 71 (10), pp. 3405-3406.
Publication Type:
Journal Article; Comment
MeSH Terms:
Hydroxychloroquine*/adverse effects
Antirheumatic Agents*
Humans ; Cross-Sectional Studies ; Tomography, Optical Coherence/methods ; Retinal Vessels ; Angiography
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Simultaneous LC-MS/MS method for the quantitation of Azithromycin, Hydroxychloroquine and its metabolites in SARS-CoV-2(-/ +) populations using dried blood spots.
Authors:
Chhonker YS; Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198-6025, USA. .
Aldhafiri WN; Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198-6025, USA.
Soni D; Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198-6025, USA.
Trivedi N; Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198-6025, USA.
Steinbronn C; Department of Pharmaceutics, University of Washington, Seattle, WA, 98195, USA.
Johnson C; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
Karita HCS; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
Paasche-Orlow MK; Department of Medicine, Tufts Medical Center, Boston, MA, 02111, USA.
Barnabas R; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA.
Arnold SL; Department of Pharmaceutics, University of Washington, Seattle, WA, 98195, USA.; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
Murry DJ; Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 68198-6025, USA. .; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .
Show more
Source:
Scientific reports [Sci Rep] 2023 Sep 30; Vol. 13 (1), pp. 16428. Date of Electronic Publication: 2023 Sep 30.
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/therapeutic use
COVID-19*
Humans ; SARS-CoV-2/metabolism ; Azithromycin/therapeutic use ; Chromatography, Liquid ; Tandem Mass Spectrometry ; COVID-19 Drug Treatment ; Communicable Disease Control
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
ABCA3 Deficiency-Variant-Specific Response to Hydroxychloroquine.
Authors:
Yang X; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Forstner M; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Rapp CK; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Rothenaigner I; Research Unit Signaling and Translation, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
Li Y; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.; Medical College, Chongqing University, Chongqing 400044, China.
Hadian K; Research Unit Signaling and Translation, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
Griese M; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 May 03; Vol. 24 (9). Date of Electronic Publication: 2023 May 03.
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/pharmacology
Hydroxychloroquine*/therapeutic use
Lung Diseases, Interstitial*/drug therapy
Lung Diseases, Interstitial*/genetics
Child ; Humans ; Retrospective Studies ; ATP-Binding Cassette Transporters/genetics ; Lung ; Mutation
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Dissimilar effects of stereoisomers and racemic hydroxychloroquine on Ca oscillations in human induced pluripotent stem cell-derived cardiomyocytes.
Authors:
Janicki PK; Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Singh A; Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Sharma AK; Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Ruiz-Velasco V; Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Show more
Source:
Physiological reports [Physiol Rep] 2023 Jul; Vol. 11 (14), pp. e15760.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/pharmacology
Induced Pluripotent Stem Cells*
Humans ; Stereoisomerism ; Myocytes, Cardiac ; Sulfates
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populations.
Authors:
Steinbronn C; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Chhonker YS; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Stewart J; Division of Infectious Diseases, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Leingang H; Department of Medicine, University of Washington, Seattle, Washington, USA.
Heller KB; Department of Medicine, University of Washington, Seattle, Washington, USA.
Krows ML; Department of Global Health, University of Washington, Seattle, Washington, USA.
Paasche-Orlow M; Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.; Division of Primary Care, Tufts Medical Center, Boston, Massachusetts, USA.
Bershteyn A; Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
Stankiewicz Karita HC; Department of Medicine, University of Washington, Seattle, Washington, USA.
Agrawal V; Center for Vaccine Development and Global Health, University of Maryland Baltimore, Baltimore, Maryland, USA.
Laufer M; Center for Vaccine Development and Global Health, University of Maryland Baltimore, Baltimore, Maryland, USA.
Landovitz R; UCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Wener M; Department of Medicine, University of Washington, Seattle, Washington, USA.
Murry DJ; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Johnston C; Department of Medicine, University of Washington, Seattle, Washington, USA.
Barnabas RV; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Arnold SLM; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Show more
Source:
Clinical and translational science [Clin Transl Sci] 2023 Jul; Vol. 16 (7), pp. 1243-1257. Date of Electronic Publication: 2023 Apr 29.
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/adverse effects
Hydroxychloroquine*/pharmacokinetics
COVID-19*
Humans ; SARS-CoV-2 ; Pandemics ; COVID-19 Drug Treatment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Increased skin reactions with hydroxychloroquine during breast radiotherapy.
Authors:
Yildirim HC; Department of Radiation Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Şahin M; Department of Radiation Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Engin B; Department of Dermatology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Öksüz DÇ; Department of Radiation Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Show more
Source:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1433-1435.
Publication Type:
Case Reports
MeSH Terms:
Hydroxychloroquine*/adverse effects
Breast Neoplasms*/drug therapy
Breast Neoplasms*/radiotherapy
Humans ; Female ; Adult ; Chloroquine/therapeutic use
Report
Full Text  Link opens in a new windowDetails
Title:
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy.
Authors:
Chen Y; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Lu M; Department of Nephrology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Lin M; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Gao Q; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.; Department of Nephrology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Show more
Source:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 347-356. Date of Electronic Publication: 2024 Jan 29.
Publication Type:
Journal Article
MeSH Terms:
Lupus Nephritis*/drug therapy
Glomerulonephritis, IGA*/drug therapy
Lupus Erythematosus, Systemic*
Humans ; Molecular Docking Simulation ; Hydroxychloroquine/pharmacology ; Hydroxychloroquine/therapeutic use ; Network Pharmacology ; Phosphatidylinositol 3-Kinases ; Inflammation
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro .
Authors:
Novelli L; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Barbati C; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Capuano C; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Recalchi S; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Ceccarelli F; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Vomero M; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Alessandri C; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Morrone S; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Conti F; Lupus Clinic, Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Show more
Source:
Lupus [Lupus] 2023 Apr; Vol. 32 (4), pp. 549-559. Date of Electronic Publication: 2023 Mar 06.
Publication Type:
Journal Article
MeSH Terms:
Hydroxychloroquine*/pharmacology
Hydroxychloroquine*/therapeutic use
Lupus Erythematosus, Systemic*
Humans ; Leukocytes, Mononuclear/metabolism ; Killer Cells, Natural ; Flow Cytometry ; Receptors, Immunologic/metabolism ; Lectins, C-Type
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus.
Authors:
Liu PC; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Luo SL; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Lv MN; The First Clinical Medical College of Nanchang University, Nanchang, China.
Wang Y; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Li JB; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yu SJ; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Wu R; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. .
Show more
Source:
Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7674. Date of Electronic Publication: 2024 Apr 01.
Publication Type:
Journal Article
MeSH Terms:
Antirheumatic Agents*/adverse effects
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Hydroxychloroquine/adverse effects ; Tandem Mass Spectrometry ; Retrospective Studies ; Toxic Optic Neuropathy/drug therapy
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Azathioprine and hydroxychloroquine overdose in Sjögren's syndrome patient with hypocalcemia: a case report.
Authors:
Kooshki A; Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Mehrpour O; Michigan Poison & Drug Information Center, School of Medicine, Wayne State University, Detroit, MI, USA.
Nakhaee S; Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran. .
Show more
Source:
Journal of medical case reports [J Med Case Rep] 2024 Feb 27; Vol. 18 (1), pp. 76. Date of Electronic Publication: 2024 Feb 27.
Publication Type:
Case Reports; Journal Article
MeSH Terms:
Hypocalcemia*/chemically induced
Sjogren's Syndrome*/complications
Sjogren's Syndrome*/drug therapy
Sjogren's Syndrome*/diagnosis
Hypokalemia*/drug therapy
Drug Overdose*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Female ; Humans ; Adult ; Hydroxychloroquine/therapeutic use ; Azathioprine/therapeutic use
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial.
Authors:
Saber M; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Farokhshahi M; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemi Naeini F; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohaghegh F; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Asilian A; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Show more
Source:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Feb; Vol. 23 (2), pp. 576-584. Date of Electronic Publication: 2023 Sep 10.
Publication Type:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Finasteride*/therapeutic use
Lichen Planus*
Humans ; Female ; Hydroxychloroquine/adverse effects ; Alopecia/drug therapy ; Alopecia/epidemiology ; Treatment Outcome ; Minoxidil
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Pharmacokinetics, Bioequivalence, and Safety of 2 Formulations of Hydroxychloroquine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Authors:
Luo HY; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Long HZ; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Zhou ZW; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Xu SG; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Li FJ; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Cheng Y; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Wen DD; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Deng P; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Gao LC; School of Pharmacy, Department of Pharmacy, Phase Ⅰ Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, University of South China, Hengyang, Hunan, China.
Show more
Source:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Mar; Vol. 12 (3), pp. 273-278. Date of Electronic Publication: 2022 Sep 01.
Publication Type:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/pharmacokinetics
Therapeutic Equivalency*
Humans ; Area Under Curve ; East Asian People ; Fasting ; Healthy Volunteers ; Tablets
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren's disease.
Authors:
Nakamura H; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Tanaka T; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Ji Y; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Zheng C; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Afione SA; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Warner BM; Salivary Disorder Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Oliveira FR; Department of Clinical Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Motta ACF; Department of Stomatology, Public Health and Forensic Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Rocha EM; Department of Ophthalmology, Otorhinolaryngology, Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Noguchi M; Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Chiorini JA; Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States of America.
Show more
Source:
PloS one [PLoS One] 2023 Feb 23; Vol. 18 (2), pp. e0282227. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/pharmacology
Hydroxychloroquine*/therapeutic use
Hydroxychloroquine*/metabolism
Sjogren's Syndrome*/drug therapy
Sjogren's Syndrome*/genetics
Sjogren's Syndrome*/metabolism
Lysosomal Membrane Proteins*/genetics
Animals ; Mice ; Chloroquine/pharmacology ; Chloroquine/therapeutic use ; Chloroquine/metabolism ; Retrospective Studies ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Salivary Glands/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 10231 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.